Novartis-along with WIRED Brand Lab and other collaborators including Techstars, Shift.ms, and the National Multiple Sclerosis Society-has launched the Innovation Prize for Assistive Tech to encourage new technologies that address the unmet needs of the multiple sclerosis community. The Novartis Innovation Prize: Assistive Tech for Multiple Sclerosis (MS) identifies and embraces technology that aims to improve mobility and daily life for people living with MS. Applications are open worldwide to the tech community, innovators, design experts, patient advocates – "anyone with an idea to make everyday life better for those with MS or mobility-limiting disabilities." Applications will be accepted until January 10, 2020 at 17:00 ET and the winners will be announced at the SXSW conference in Austin, Texas on March 13, 2020. In order to develop their innovation, the first-place winner will receive a prize worth $250,000 and the second-place winner will receive $50,000.* *More information can be found at www.wired.com/msinnovationprize
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
Efsitora Demonstrates Non-Inferiority vs. Insulin Glargine, Degludec for Type 2 Diabetes
September 5th 2024Results from the QWINT-1 and QWINT-3 trials found that insulin-naïve patients achieved similar reductions in A1C levels using once-weekly efsitora compared to daily insulin glargine and degludec.